These reports were supported by the fact that anti-TNFR2 antibodies impaired the immunosuppressive function of TNFR2+Tregs on T-eff cells in BC via reducing FoxP3 overexpression [8]. This evidence concerns the gene TNFRSF1B and breast cancer.